Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2020 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Return on Invested Capital for 7 consecutive years, with 0.35% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 6.0% to 0.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.35% through Dec 2025, down 6.0% year-over-year, with the annual reading at 0.12% for FY2025, 28.0% up from the prior year.
  • Return on Invested Capital hit 0.35% in Q4 2025 for Ironwood Pharmaceuticals, up from 1.36% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 8.2% in Q3 2023 to a low of 3.92% in Q2 2023.
  • Historically, Return on Invested Capital has averaged 0.97% across 5 years, with a median of 0.07% in 2022.
  • Biggest five-year swings in Return on Invested Capital: skyrocketed 813bps in 2023 and later crashed -818bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.16% in 2021, then tumbled by -48bps to 0.08% in 2022, then skyrocketed by 9162bps to 7.53% in 2023, then tumbled by -104bps to 0.29% in 2024, then fell by -19bps to 0.35% in 2025.
  • Business Quant data shows Return on Invested Capital for IRWD at 0.35% in Q4 2025, 1.36% in Q3 2025, and 0.29% in Q2 2025.